SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in SpringWorks Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 148
- +5 vs. Q2 2022
- Shares held
- 63.3M
- +7.99M (+14.5%) vs. Q2 2022
- Total value
- $1.80B
- +$436.4M (+32.0%) vs. Q2 2022
- New holders
- 25
- 56 more added
- Sold out
- 20
- 44 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $47 |
| Q1 2026 | 1 | $47 |
| Q4 2025 | 2 | $2.18M |
| Q3 2025 | 3 | $2.16M |
| Q2 2025 | 223 | $3.65B |
| Q1 2025 | 306 | $3.29B |
| Q4 2024 | 216 | $2.92B |
| Q3 2024 | 226 | $2.59B |
| Q2 2024 | 209 | $2.91B |
| Q1 2024 | 217 | $3.85B |
| Q4 2023 | 180 | $2.75B |
| Q3 2023 | 147 | $1.58B |
| Q2 2023 | 142 | $1.82B |
| Q1 2023 | 149 | $1.70B |
| Q4 2022 | 137 | $1.73B |
| Q3 2022 | 148 | $1.80B |
| Q2 2022 | 144 | $1.36B |
| Q1 2022 | 136 | $2.79B |
| Q4 2021 | 144 | $2.82B |
| Q3 2021 | 142 | $2.86B |
| Q2 2021 | 135 | $3.69B |
| Q1 2021 | 137 | $3.23B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding SpringWorks Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameriprise Financial Inc | 143,386 | $4.09M | 0.00% | +143,386 | New |
| D. E. Shaw & Co., Inc. | 145,610 | $4.15M | 0.01% | −99,853−40.7% | Reduced |
| Adage Capital Partners GP, L.L.C. | 150,000 | $4.28M | 0.01% | −425,000−73.9% | Reduced |
| Bank of New York Mellon Corp | 150,454 | $4.29M | 0.00% | +22,733+17.8% | Added |
| Barclays PLC | 152,373 | $4.35M | 0.00% | +139,337+1,068.9% | Added |
| Two Sigma Advisers, LP | 153,000 | $4.37M | 0.01% | +4,600+3.1% | Added |
| Candriam Luxembourg S.C.A. | 162,109 | $4.63M | 0.03% | 00.0% | Unchanged |
| Citadel Advisors LLC | 166,995 | $4.76M | 0.01% | +37,580+29.0% | Added |
| Millennium Management LLC | 170,597 | $4.87M | 0.01% | +106,925+167.9% | Added |
| Cubist Systematic Strategies, LLC | 170,901 | $4.88M | 0.04% | +34,386+25.2% | Added |
| Affinity Asset Advisors, LLC | 175,000 | $4.99M | 2.30% | +175,000 | New |
| New York State Common Retirement Fund | 208,635 | $5.95M | 0.01% | +18,985+10.0% | Added |
| Citigroup Inc | 224,430 | $6.40M | 0.01% | −29,632−11.7% | Reduced |
| Charles Schwab Investment Management Inc | 237,543 | $6.78M | 0.00% | +31,560+15.3% | Added |
| Bessemer Group Inc | 241,337 | $6.88M | 0.02% | 00.0% | Unchanged |
| Rafferty Asset Management, LLC | 244,364 | $6.97M | 0.07% | +69,660+39.9% | Added |
| Price T Rowe Associates Inc | 248,855 | $7.10M | 0.00% | +7,412+3.1% | Added |
| Driehaus Capital Management LLC | 274,111 | $7.82M | 0.12% | −891,713−76.5% | Reduced |
| Sphera Funds Management Ltd. | 301,625 | $8.61M | 1.52% | −235,039−43.8% | Reduced |
| Finepoint Capital LP | 308,092 | $8.79M | 2.89% | +308,092 | New |
| Northern Trust Corp | 308,487 | $8.80M | 0.00% | +7,966+2.7% | Added |
| Norges Bank | 357,694 | $10.2M | 0.00% | −154,199−30.1% | Reduced |
| JPMorgan Chase & Co | 386,342 | $11.0M | 0.00% | −140,487−26.7% | Reduced |
| Laurion Capital Management LP | 396,666 | $11.3M | 0.31% | +21,703+5.8% | Added |
| Massachusetts Financial Services Co | 420,702 | $12.0M | 0.00% | +28,005+7.1% | Added |
| Voloridge Investment Management, LLC | 450,994 | $12.9M | 0.07% | +8,662+2.0% | Added |
| Phoenix Holdings Ltd. | 489,444 | $13.3M | 0.29% | −413,423−45.8% | Reduced |
| Goldman Sachs Group Inc | 485,353 | $13.8M | 0.00% | +214,666+79.3% | Added |
| Nicholas Investment Partners, LP | 557,175 | $15.9M | 1.47% | +557,175 | New |
| Fiera Capital Corp | 630,968 | $16.4M | 0.06% | −7,897−1.2% | Reduced |
| Geode Capital Management, LLC | 618,894 | $17.7M | 0.00% | +61,230+11.0% | Added |
| Morgan Stanley | 755,617 | $21.6M | 0.00% | +257,965+51.8% | Added |
| Deerfield Management Company, L.P. (Series C) | 816,994 | $23.3M | 0.47% | +816,994 | New |
| Victory Capital Management Inc | 936,747 | $26.7M | 0.03% | −42,847−4.4% | Reduced |
| Pictet Asset Management SA | 1,105,540 | $31.5M | 0.05% | +1,963+0.2% | Added |
| Bank of America Corp | 1,709,776 | $48.8M | 0.01% | +63,433+3.9% | Added |
| Artal Group S.A. | 2,053,403 | $58.6M | 3.06% | +1,153,403+128.2% | Added |
| Deep Track Capital, LP | 2,369,210 | $67.6M | 3.34% | +2,369,210 | New |
| ArrowMark Colorado Holdings LLC | 2,550,779 | $72.8M | 0.89% | −745,571−22.6% | Reduced |
| BlackRock Inc. | 2,821,344 | $80.5M | 0.00% | +201,887+7.7% | Added |
| Vanguard Group Inc | 3,196,045 | $91.2M | 0.00% | +451,928+16.5% | Added |
| State Street Corp | 3,324,062 | $94.8M | 0.01% | −565,187−14.5% | Reduced |
| Boxer Capital, LLC | 3,421,541 | $97.6M | 5.49% | +1,345,636+64.8% | Added |
| EcoR1 Capital, LLC | 3,460,208 | $98.7M | 2.92% | +3,460,208 | New |
| Perceptive Advisors LLC | 3,470,563 | $99.0M | 2.88% | −396,883−10.3% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 4,831,307 | $137.8M | 16.45% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 5,525,926 | $157.7M | 3.13% | −502,381−8.3% | Reduced |
| FMR LLC | 9,360,160 | $263.3M | 0.03% | +1,948,120+26.3% | Added |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −506,772−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −475,000−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −107,022−100.0% | Sold out |
| TCW Group Inc | 0 | $0 | 0.00% | −74,671−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −65,949−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −41,184−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −30,948−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −22,196−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −15,681−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −12,200−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,329−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −7,335−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −5,531−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −3,300−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,014−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −1,993−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −401−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −119−100.0% | Sold out |
| Moisand Fitzgerald Tamayo, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Fieldpoint Private Securities, LLC | – | – | – | – | Not filed |